These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3458566)

  • 21. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.
    Zeiler HJ
    Drugs Exp Clin Res; 1985; 11(5):335-8. PubMed ID: 2941261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G; Tulunay C
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methicillin-sensitive Staphylococcus aureus tricuspid valve endocarditis with annular abscess cured with oral levofloxacin and rifampicin.
    Foo SS; Lye DC
    Int J Antimicrob Agents; 2007 Sep; 30(3):275-7. PubMed ID: 17644346
    [No Abstract]   [Full Text] [Related]  

  • 27. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection.
    Rajendran PM; Young D; Maurer T; Chambers H; Perdreau-Remington F; Ro P; Harris H
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4044-8. PubMed ID: 17846141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ofloxacin treatment in the management of chronic osteitis.
    Ketterl R; Beckurts T; Stübinger B; Claudi B
    Drugs; 1987; 34 Suppl 1():124-30. PubMed ID: 3481313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ofloxacin treatment of difficult infections of the skin and skin structure.
    Gentry LO; Rodriguez-Gomez G
    Cutis; 1993 Jan; 51(1):55-8. PubMed ID: 8419113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Our experience with ofloxacin in the treatment of osteoarticular infections].
    Lopitaux R; Hermet R; Sirot J; Terver S; Levai JP
    Pathol Biol (Paris); 1988 May; 36(5):557-61. PubMed ID: 3043357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial Abscess Formation Is Controlled by the Stringent Stress Response and Can Be Targeted Therapeutically.
    Mansour SC; Pletzer D; de la Fuente-Núñez C; Kim P; Cheung GYC; Joo HS; Otto M; Hancock REW
    EBioMedicine; 2016 Oct; 12():219-226. PubMed ID: 27658736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ofloxacin: bactericidal effect in an in vitro pharmacokinetic model.
    Xerri L; Broggio R; Guerra L
    Chemioterapia; 1986 Apr; 5(2):83-7. PubMed ID: 3085961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of azithromycin, roxithromycin, and cephalexin penetration kinetics in early and mature abscesses.
    Girard D; Bergeron JM; Milisen WB; Retsema JA
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():17-28. PubMed ID: 8396089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of iNOS inhibitor LNMMA along with antibiotics Chloramphenicol or Ofloxacin in murine peritoneal macrophages regulates S.aureus infection as well as inflammation: An in vitro study.
    Dey S; Bishayi B
    Microb Pathog; 2017 Apr; 105():307-320. PubMed ID: 28242423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
    Soussy CJ; Deforges L; Le Van Thoi J; Duval J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection.
    Trampuz A; Murphy CK; Rothstein DM; Widmer AF; Landmann R; Zimmerli W
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2540-5. PubMed ID: 17502404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Refractory respiratory tract infections. 6. New problems in refractory respiratory tract infections. c. Chemotherapy of methicillin-resistant Staphylococci infection].
    Konno M
    Nihon Rinsho; 1987 Mar; 45(3):565-70. PubMed ID: 3298734
    [No Abstract]   [Full Text] [Related]  

  • 39. Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice.
    Pattyn SR
    Antimicrob Agents Chemother; 1987 Apr; 31(4):671-2. PubMed ID: 3475035
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical pharmacology of ofloxacin: a new chemotherapeutic agent belonging to the gyrase inhibitor group].
    Verho M; Dagrosa EE; Malerczyk V
    Infection; 1986; 14 Suppl 1():S47-53. PubMed ID: 3007366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.